Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation™ (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/17/12 | $10,000,000 | Series A |
Third Rock Ventures | undisclosed |
